Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN

Kidney International

Volumn 68, Issue 3, 2005, Pages 1078-1085

  Nishitani, Yoshiharu ^b   Iwano, Masayuki ^b   Yamaguchi, Yukinari ^b   Harada, Koji ^b   Nakatani, Kimihiko ^b   Akai, Yasuhiro ^b   Nishino, Toshihiko ^b   Shiiki, Hideo ^b   Kanauchi, Masao ^b   Saito, Yoshihiko ^b   Neilson, Eric G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

And multivariate analysis; Epithelial mesenchymal transition; Fibroblast specific protein 1; IgA nephropathy; Interstitial fibrosis; Renal failure

Indexed keywords

FIBROBLAST SPECIFIC PROTEIN 1; IMMUNOGLOBULIN A; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; SURVIVAL; URINARY EXCRETION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; CALCIUM-BINDING PROTEINS; CREATININE; FEMALE; FIBROBLASTS; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 32644473830     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00500.x     Document Type: Article

References (36)

1. DONADIO JV, JR., GRANDE JP: Immunoglobulin A nephropathy: A clinical perspective. J Am Soc Nephrol 8:1324-1332, 1997
2. JULIAN BA, WALDO FB, RIFAI A, MESTECKY J: IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med 84:129-132, 1988
3. ENDO Y: IgA nephropathy - Human disease and animal model. Ren Fail 19:347-371, 1997
4. GALLA JH: IgA nephropathy. Kidney Int 47:377-387, 1995
5. PETTERSSON E: IgA nephropathy: 30 years on. J Intern Med 242:349-353, 1997
6. D'AMICO G: Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature. Am J Kidney Dis 20:315-323, 1992
7. LI PK, HO KK, SZETO CC, et al: Prognostic indicators of IgA nephropathy in the Chinese - Clinical and pathological perspectives. Nephrol Dial Transplant 17:64-69, 2002
8. D'AMICO G: Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am J Kidney Dis 36:227-237, 2000
9. DANIEL L, SAINGRA Y, GIORGI R, et al: Tubular lesions determine prognosis of IgA nephropathy. Am J Kidney Dis 35:13-20, 2000
10. KOYAMA A, IGARASHI M, KOBAYASHI M: Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Am J Kidney Dis 29:526-532, 1997
11. BARTOSIK LP, LAJOIE G, SUGAR L, CATTRAN DC: Predicting progression in IgA nephropathy. Am J Kidney Dis 38:728-735, 2001
12. D'AMICO G, RAGNI A, GANDINI E, FELLIN G: Typical and atypical natural history of IgA nephropathy in adult patients. Contrib Nephrol 104:6-13, 1993
13. CHAUVEAU D, DROZ D: Follow-up evaluation of the first patients with IgA nephropathy described at Necker Hospital. Contrib Nephrol 104:1-5, 1993
14. FOFI C, PECCI G, GALLIANI M, et al: IgA nephropathy: Multivariate statistical analysis aimed at predicting outcome. J Nephrol 14:280-285, 2001
15. HEBERT LA: Renoprotective therapy: How good can it get? Kidney Int 57:343-344, 2000
16. RYCHLIK I, ANDRASSY K, WALDHERR R, et al: Clinical features and natural history of IgA nephropathy. Ann Med Interne (Paris) 150:117-126, 1999
17. TO KF, CHOI PC, SZETO CC, et al: Outcome of IgA nephropathy in adults graded by chronic histological lesions. Am J Kidney Dis 35:392-400, 2000
18. RADFORD MG, JR., DONADIO JV, JR., BERGSTRALH EJ, GRANDE JP: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8:199-207, 1997
19. WAKAI K, KAWAMURA T, MATSUO S, et al: Risk factors for IgA nephropathy: A case-control study in Japan. Am J Kidney Dis 33:738-745, 1999
20. BOHLE A, STRUTZ F, MULLER GA: On the pathogenesis of chronic renal failure in primary glomerulopathies: A view from the interstitium. Exp Nephrol 2:205-210, 1994
21. STRUTZ F, OKADA H, LO CW, et al: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130:393-405, 1995
22. IWANO M, PLIETH D, DANOFF TM, et al: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350, 2002
23. IWANO M, FISCHER A, OKADA H, et al: Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther 3:149-159, 2001
24. BALLARDIE FW, ROBERTS IS: Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 13:142-148, 2002
25. KATAFUCHI R, OH Y, HORI K, et al: An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis. Clin Nephrol 41:191-198, 1994
26. COCKCROFT DW, GAULT MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
27. BARRACLOUGH R: Calcium-binding protein S100A4 in health and disease. Biochim Biophys Acta 1448:190-199, 1998
28. OKADA H, DANOFF TM, KALLURI R, NEILSON EG: Early role of FSP1 in epithelial-mesenchymal transformation. Am J Physiol 273:F563-F574, 1997
29. XUE C, PLIETH D, VENKOV C, et al: The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 63:3386-3394, 2003
30. AMBARTSUMIAN N, KLINGELHOFER J, GRIGORIAN M, et al: The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene 20:4685-4695, 2001
31. CHEN H, FERNIG DG, RUDLAND PS, et al: Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka). Biochem Biophys Res Commun 286:1212-1217, 2001
32. GRIGORIAN M, ANDRESEN S, TULCHINSKY E, et al: Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: Functional consequences of their interaction. J Biol Chem 276:22699-22708, 2001
33. STRUTZ F, NEILSON EG: New insights into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol 24:459-476, 2003
34. DONADIO JV, BERGSTRALH EJ, OFFORD KP, et al: Clinical and histopathologic associations with impaired renal function in IgA nephropathy. Mayo Nephrology Collaborative Group. Clin Nephrol 41:65-71, 1994
35. OKADA H, BAN S, NAGAO S, et al: Progressive renal fibrosis in murine polycystic kidney disease: An immunohistochemical observation. Kidney Int 58:587-597, 2000
36. FRID MG, KALE VA, STENMARK KR: Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res 90:1189-1196, 2002